All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
COVID-19 infection, vaccination have little effect on migraine worsening
Oct 04, 2023
An increased concern about migraine worsening was a risk factor for perceived migraine worsening.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Biden administration says insurance issues with COVID-19 shots mostly fixed
Sep 29, 2023
More than 2 million people already had received the updated vaccines by Wednesday, according to HHS.
Flu vaccine uptake varies by sociodemographic factors in CKD patients
Sep 26, 2023
Just under three-quarters of patients with chronic kidney disease receive flu vaccines
CDC panel gives support to new COVID-19 booster shots
Sep 13, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
FDA approval of new COVID-19 boosters could come by Friday
Sep 07, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Moderna says updated COVID-19 vaccine shields against highly mutated new variant
Sep 06, 2023
Scientists found that the variant appears to be less concerning than initially thought, with data showing that it is 60% less infectious than XBB.1.5 variants.
Some immunosuppressed do not have anti-spike antibodies after COVID-19 vaccination
Aug 30, 2023
IgG anti-spike antibodies were undetectable in ~20% with immunosuppression who had received three or more COVID-19 vaccines.
Education on approval process may increase acceptance of new RSV vaccines
Aug 14, 2023
Just 13% of respondents knew about the existence of an approved vaccine against RSV for older adults. Those educated on vaccine approval process or about potential severity of RSV may be more accepting.